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Stokes Bio, founded in 2005, develops innovative microfluidic technologies. In 2008 in 
collaboration with Monsanto an application driven development for a high throughput instrument  ,       -   
in the detection and characterisation of Single Nucleotide Polymorphisms (SNPs) in agricultural 
crops was initiated. 
Stokes technology is designed to generate aqueous nanolitre scale droplets of reagents and 
samples, wrapped in a carrier fluid from standard microtitre plates and to mix them using Stokes 
Bio’s proprietary liquid bridge mixers. Following mixing the complete assay is transferred in the 
carrier fluid through the use of a continuous flow system to a flow through thermal cycler and an         ,         
optical reading station. 
This poster summarises results collated using the Stokes Bio genotyping platform currently 
based in Monsanto. Data will be presented to illustrate the dynamic capabilities of the 
instrument, highlighting the enhanced sensitivity and reproducibility of PCR in droplet format 
compared to well-based technologies.
Stokes Bio Technology
Stokes Bio technology is unique in a number of ways:         
 The reaction vessel is a droplet, not a well.
 High reaction throughput capabilities.
 Highly efficient nanoscale reaction volume.
 Exceptional arraying capability and flexibility.
 L t tiow reagen  consump on.
Technology Background 
 The reaction vessel is a droplet, which flows through teflon tubing in a continuous oil flow
format thus resulting in trains of aqueous droplets as shown in Figure 1 These aqueous droplets.
are approximately 300nl in volume and are separated by the carrier oil. The droplets are
completely wrapped by this carrier oil thus generating a micron scale film between the droplets
and the tubing wall. The droplet volume and separation is controllable. As the system is modular,
parallel lines enable high throughput capability.
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FIGURE 1: A schematic and an image of a densely
packed droplet train using dyed aqueous droplets in a
samp e presen
carrier oil.
 Droplets are mixed in Stokes Bio’s proprietary liquid bridge. A schematic of a liquid bridge
tower is shown in Figure 2. These bridges facilitate the mixing of nanoliter-scale droplets,
containing master mix, reagents and DNA sample, in a precise and controlled fashion.
Gene Assay Inlet Liquid 
Bridges FIGURE 2: Schematic of Stokes Bio
liquid bridge technology. This figure
shows a partially assembled three way
6X bridge stacked in a tower format.
This can be increased to a 96 Bridge
Master Mix
-
format (24 x 4 towers) allowing an
increase in mixing throughput.
DNA Sample Inlet
 
Stokes Bio technology utilises common laboratory consumables. The PCR reaction is prepared
and aliquoted into two microtitre plates, the PCR gene assays are put into one plate and the
DNA samples of interest are placed into the other. The master mix is placed in a separate
reaction vessel. The aqueous solutions are then overlaid with a carrier oil as shown in Figure 3.
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FIGURE 3: Stokes Bio platform set
up. This figure shows the two microtitre
plates and a single liquid bridge.
 Tubing extends from the liquid bridge and is dipped into each reaction plate using a robotic
liquid handling system. Droplets of DNA, gene assay and master mix are formed and mixed in
the liquid bridge. This segregation of the PCR components enables a truly flexible instrument as
any DNA sample can be arrayed against any gene of interest in nanoliter volume reactions.
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 Following mixing in the liquid bridge the droplet train flows through the required thermal
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zones for amplification. A schematic of a Stokes Bio thermal cycler is shown in Figure 4. A
laser, optical fibres and cameras form the optical system that detects fluorescence signal due
to amplification. For real-time PCR, the droplet fluorescence is read at each cycle whereas
in genotyping the fluorescence is only measured at the end point. The resulting signal from
each droplet is then analysed by software and amplification curves or allelograms can be
generated depending on the application.
Figure 4: The thermal cycler is
made up of two blocks that are
heated to the required
temperature for amplification.
The tubing meanders in and
out of these thermal zones
thus resulting in PCR cycles.
Genotyping at Monsanto
Monsanto aims to double its year 2000 yields in core crops of corn, cotton and soybeans
by 2030 while simultaneously reducing by a third the amount of inputs, such as water,
energy and fertilizer needed per unit produced To assist in achieving this goal Monsanto, .
requires a significant increase in their genotyping throughput capacity while reducing cost.
The Stokes Bio instrument is beneficial to Monsanto in three ways. Firstly, the throughput
can be increased by parallelising the liquid bridges and the thermal cyclers. The Stokes Bio
instrument can achieve tens of thousands of data points per hour. Secondly, the cost per
reaction is also reduced due to the nanoliter volumes used. Finally, the unique sampling
technique enables exceptional flexibility so that any DNA versus gene combination can be
performed.
The following experiments were performed to
demonstrate the enhanced sensitivity and
reproducibility of PCR in droplet format
compared to well-based technologies.
Extracted DNA from soy seed was amplified
on Monsanto’s current high throughput
genotyping process. The same extracted soy
DNA was amplified on the Stokes Bio
genotyping instrument at Monsanto shown in
Figure 5: Stokes Bio genotyping InstrumentFigure 5.
In both cases three polymorphic soy SNP markers were investigated and the resulting
genotyping data was examined and visualized in allelograms Allelograms A C in Figure 6. -
represent individual markers ran on Monsanto’s current high throughput genotyping process.
Allelogram D represents 96 DNA samples ran on the Stokes Bio instrument against all three
polymorphic SNP markers.
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Figure 6: Allelogram for soy makers run on current in house genotyping process in Monsanto (A C)
The allelogram from the Monsanto PCR process (Figure 6 A-C) is very disperse which makes
accurate genotyping calling difficult. The resulting allelogram from the Stokes Bio instrument
        -      -  . 
The same soy markers were run on the Stokes Bio instrument and are presented in allelogram D. 
(Figure 6 D) is more tightly clustered and thus easier to score. Scoring algorithms can be
easily and more confidently applied to an allelogram that give distinctive clusters. Stokes Bio
technology enables more accurate calling and facilitates a faster turn around time between
d l i d l tisee ana ys s an p an ng.
Conclusion
Stokes Bio technology offers improved functionality over existing systems that suffer from
high reagents costs and an inability to array multiple DNA samples against multiple gene
assays in a flexible format. As presented in Figure 6, the Stokes Bio instrument yielded a
superior clustering allelogram plot compared to the current process at Monsanto. This was
also achieved at a reduced reagent cost per data point and at a higher throughput. Stokes Bio
technology will have a major impact on genotyping at Monsanto and indeed our novel
technology will be extended into the real-time PCR and digital PCR space also
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